 This pivotal study follows the successful completion of EyeGates pilot study in early 2020. The pivotal study will evaluate the effectiveness and safety of EyeGates Ocular Bandage Gel eye drop in reducing PEs in a dry eye patient population to be further defined in the IDE. Prior to filing the IDE application for the pivotal study, the Company must perform additional testing for the new packaging, a multi-dose preservative-free bottle, as previously discussed with the FDA. 